RX+
LIVE

Serial Number

97829214

Owner

Astellas Pharma Inc.

Attorney

Christopher Bolinger

Filing Date

Mar 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

RX+ Trademark

Serial Number: 97829214

RX+ is a trademark filed by Astellas Pharma Inc. on March 8, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Astellas Pharma Inc.

5-1, Nihonbashi-Honcho 2-chome,
Chuo-ku, Tokyo 103-8411 , JP

Entity Type: 03

Trademark Details

Filing Date

March 8, 2023

Registration Date

Not Registered

Published for Opposition

October 24, 2023

Goods & Services

Instruction in the field of dosage management; entertainment services, namely, providing online computer games; providing therapeutic exercise instruction; sports club services, namely, physical fitness instruction

Medical apparatus for detecting and treating for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct and diagnostic imaging

Providing temporary use of on-line non-downloadable computer programs for use in medical examination for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct; scientific research and development; medical research and development; providing scientific research information in the field of clinical trials

Medical service; medical diagnostic testing services; surgery support services related to medical care for type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct

Downloadable medical software for processing and displaying images on ultrasound medical imaging machines; downloadable computer software for controlling and managing patient medical information; downloadable medical software for processing and displaying affected part images on medical resonance imaging machines (MRIs); downloadable software for medical imaging equipment, namely, for interpreting the results of CT scanners; downloadable computer programs for use in the operation of medical ultrasound detectors; downloadable computer software for medical examination for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct and for conducting medical diagnostic testing

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 3, 2026 EXRA
SOU EXTENSION 5 GRANTED
Jun 3, 2026 EX5G
SOU TEAS EXTENSION RECEIVED
Jun 2, 2026 EEXT
SOU EXTENSION 5 FILED
Jun 1, 2026 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 27, 2026 EXRA
SOU EXTENSION 4 GRANTED
Feb 26, 2026 EX4G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 26, 2026 AITU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jan 19, 2026 TPEX
NOTICE OF REVIVAL - E-MAILED
Jan 19, 2026 NREV
PETITION TO REVIVE-GRANTED
Jan 19, 2026 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 19, 2026 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 19, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 19, 2026 ABN6
SOU EXTENSION 4 FILED
Dec 19, 2025 EXT4
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jun 11, 2025 EX3G
SOU EXTENSION 3 FILED
Jun 11, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 11, 2025 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 14, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 14, 2025 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Apr 14, 2025 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 14, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 14, 2025 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
Nov 28, 2024 EX2G
SOU EXTENSION 2 FILED
Nov 28, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 28, 2024 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 9, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 9, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 9, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 9, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 9, 2024 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jun 13, 2024 EX1G
SOU EXTENSION 1 FILED
Jun 13, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 13, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 19, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 24, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 14, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 10, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 10, 2023 GNRT
NON-FINAL ACTION WRITTEN
Aug 10, 2023 CNRT
ASSIGNED TO EXAMINER
Jul 28, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 28, 2023 NWOS
NEW APPLICATION ENTERED
Mar 11, 2023 NWAP